Precision measurement of the branching ratio in the 6P3/2 decay of BaII with a single trapped ion

We present a measurement of the branching ratios from the 6P3/2 state of BaII into all dipoleallowed decay channels (6S1/2, 5D3/2 and 5D5/2). Measurements were performed on single 138Ba+ ions in a linear Paul trap with a frequency-doubled mode-locked Ti:Sapphire laser resonant with the 6S1/2->6P3/2 transition at 455 nm by detection of electron shelving into the dark 5D5/2 state. By driving a pi Rabi rotation with a single femtosecond pulse, a absolute measurement of the branching ratio to 5D5/2 state was performed. Combined with a measurement of the relative decay rates into 5D3/2 and 5D5/2 states performed with long trains of highly attenuated 455 nm pulses, it allowed the extraction of the absolute ratios of the other two decays. Relative strengths normalized to unity are found to be 0.756+/-0.046, 0.0290+/-0.0015 and 0.215+/-0.0064 for 6S1/2, 5D3/2 and 5D5/2 respectively. This approximately constitutes a threefold improvement over the best previous measurements and is a sufficient level of precision to compare to calculated values for dipole matrix elements.Comment: 6 pages, 5 figures, 1 tabl

Barium Ions for Quantum Computation

Individually trapped 137Ba+ in an RF Paul trap is proposed as a qubit ca ndidate, and its various benefits are compared to other ionic qubits. We report the current experimental status of using this ion for quantum computation. Fut ure plans and prospects are discussed

Quantitative single-particle digital autoradiography with α

PURPOSE: Alpha-emitting radionuclides exhibit a potential advantage for cancer treatments because they release large amounts of ionizing energy over a few cell diameters (50–80 μm), causing localized, irreparable double-strand DNA breaks that lead to cell death. Radioimmunotherapy (RIT) approaches using monoclonal antibodies labeled with α emitters may thus inactivate targeted cells with minimal radiation damage to surrounding tissues. Tools are needed to visualize and quantify the radioactivity distribution and absorbed doses to targeted and nontargeted cells for accurate dosimetry of all treatment regimens utilizing α particles, including RIT and others (e.g., Ra-223), especially for organs and tumors with heterogeneous radionuclide distributions. The aim of this study was to evaluate and characterize a novel single-particle digital autoradiography imager, the ionizing-radiation quantum imaging detector (iQID) camera, for use in α-RIT experiments. METHODS: The iQID camera is a scintillator-based radiation detection system that images and identifies charged-particle and gamma-ray/x-ray emissions spatially and temporally on an event-by-event basis. It employs CCD-CMOS cameras and high-performance computing hardware for real-time imaging and activity quantification of tissue sections, approaching cellular resolutions. In this work, the authors evaluated its characteristics for α-particle imaging, including measurements of intrinsic detector spatial resolutions and background count rates at various detector configurations and quantification of activity distributions. The technique was assessed for quantitative imaging of astatine-211 ((211)At) activity distributions in cryosections of murine and canine tissue samples. RESULTS: The highest spatial resolution was measured at ∼20 μm full width at half maximum and the α-particle background was measured at a rate as low as (2.6 ± 0.5) × 10(−4) cpm/cm(2) (40 mm diameter detector area). Simultaneous imaging of multiple tissue sections was performed using a large-area iQID configuration (ø 11.5 cm). Estimation of the (211)At activity distribution was demonstrated at mBq/μg-levels. CONCLUSIONS: Single-particle digital autoradiography of α emitters has advantages over traditional film-based autoradiographic techniques that use phosphor screens, in terms of spatial resolution, sensitivity, and activity quantification capability. The system features and characterization results presented in this study show that the iQID is a promising technology for microdosimetry, because it provides necessary information for interpreting alpha-RIT outcomes and for predicting the therapeutic efficacy of cell-targeted approaches using α emitters